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ABSTRACT
Previousstudiesinourlaboratoryprovedthatcertain
functional groups are able to mimic the pyro-
phosphate moiety and act as leaving groups in the
enzymatic polymerization of deoxyribonucleic acids
by HIV-1 reverse transcriptase. When the potential
leaving group possesses two carboxylic acid
moieties linked to the nucleoside via a
phosphoramidate bond, it is efficiently recognized
by this error-prone enzyme, resulting in nucleotide
incorporation into DNA. Here, we present a new
efficient alternative leaving group, iminodiacetic
acid, which displays enhanced kinetics and an
enhanced elongation capacity compared to
previous results obtained with amino acid
deoxyadenosine phosphoramidates. Iminodiacetic
acid phosphoramidate of deoxyadenosine
monophosphate (IDA-dAMP) is processed by HIV-1
RT as a substrate for single nucleotide incorporation
and displays a typical Michaelis–Menten kinetic
profile. This novel substrate also proved to be
successful in primer strand elongation of a seven-
base template overhang. Modelling of this new
substrate in the active site of the enzyme revealed
that the interactions formed between the
triphosphate moiety, magnesium ions and enzyme’s
residues could be different from those of the natural
triphosphate substrate and is likely to involve addi-
tional amino acid residues. Preliminary testing for a
potential metabolic accessibility lets us to envision
its possible use in an orthogonal system for nucleic
acid synthesis that would not influence or be
influenced by genetic information from the outside.
INTRODUCTION
The aim of our project is to develop and introduce addi-
tional types of nucleic acids in living cells. As a long term
objective, these nucleic acids could be used to avert genetic
pollution by preventing dissemination of artiﬁcial heredi-
tary messages in natural ecosystems, including the human
body (1). In formal terms, this project amounts to
systematical searching of the chemical space in order
to identify an assortment of activated monomers
carrying a set of complementary bases. Another aspect
of this project is to discover nucleic acid enzymes
that would use activated monomers as substrates
in polymerization, ligation or recombination. The result
of this interplay would be templated reproduction of poly-
mers which would convey additional genetic information
but not interfere with RNA and DNA metabolism and
function.
Base and backbone variants of DNA and RNA are
the topic of intense research in several laboratories,
auguring well for the feasibility of xeno-nucleic acid
(XNA) reproduction in vivo (2–4). Even though it will
not be part of the propagated polymers per se, the
leaving group to be used for activating XNA precursors
is in our opinion crucial. Indeed, the chemical structure
of the leaving group can be elaborated leading to
segregation of the polymerization of XNA polymers
from that of indigenous DNA and RNA monomers and
establishing an informational enclave. Simultaneously,
it could disentangle the XNA polymerization from the
phosphoanhydride economy of the cell, hence establishing
an energetic enclave as well. The dual role of nucleoside
triphosphates, as both energetic currency and precursors
of the informational polymers RNA and DNA, drastically
limits the range of metabolic and genetic reprogramming
that can be accomplished in living cells. The judicious
implementation of novel leaving groups in metabolism
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talization of unnatural information transfers and enable
the launching and sustaining of autonomous hereditary
procedures in vivo.
We previously showed that the common metabolite
aspartate coupled to the phosphate group of deoxynucleo-
tides by a P–N phosphoramidate bond provides unnatural
adducts acting as competent substrates in the HIV-1 RT
directed template-dependent DNA polymerization (5–7).
Through broadening our search of the chemical space we
addressed the synthesis and enzymatic assay of the
deoxyadenylate adduct of iminodiacetate. Although this
isomer is not commonly found in living cells, its biosyn-
thesis and recycling from glycine and glyoxylate could be
readily implemented in metabolism. Formation of the pro-
totype metabolite triphospho-imino-diacetate (TPI) and
its reaction with nucleosides can also be experimentally
studied to investigate novel energetic and informational
metabolism and its potential implementation in bacterial
cells.
The enzymatic synthesis of nucleic acids makes use
of nucleoside triphosphates as substrates and this process
is driven forward by the release and hydrolysis of
pyrophosphate. The selection of new leaving groups for
the enzymatic synthesis of nucleic acids should be
accompanied by a selection of appropriate polymerases
(6), which can use the modiﬁed nucleotides as building
blocks for gene synthesis independent of the cellular
gene-synthesis machinery. Since HIV-1 RT shows broad
substrate speciﬁcity, this enzyme was chosen as a primary
polymerase for selection of potential leaving groups to
activate nucleoside triphosphate mimics.
Despite the fact that such polymerases as HIV-1 reverse
transcriptase (6), Taq DNA polymerase and Vent (exo-)
DNA polymerase (6) are able to process selected
substrates like amino acid dAMP phosphoramidates,
HIV-1 RT is being the preferred enzyme. In our study
the pyrophosphate leaving group (linked to a
deoxynucleotide in Figure 1a) is replaced by a completely
diﬀerent molecule with potential chelating properties.
It has been indicated that the L-aspartic acid derivatives
of dATP (Figure 1b) (6), dGTP, dCTP and dTTP
(7) demonstrated conserved single nucleotide incorpora-
tion and limited elongation properties. Incorporation of
L-His-dAMP by HIV-1 RT however proceeded with lower
eﬃciency. However in contrast to its congener L-Asp-
dAMP, primer chain elongation was slightly improved
when L-His-dAMP was used (6). It is important to
note that regardless of a phosphoramidate mimic, DNA
synthesis dramatically slowed down after incorporation
of 2nt. The reason for this stalling is not clear. The
stalling issue might be a major hurdle for the use
of such modiﬁed nucleotides for enzyme-catalyzed DNA
synthesis in vivo.
A model postulated by Steitz explains the way by
which the incoming deoxynucleotide triphosphate
(dNTP) is bound in the active site of the polymerase
for incorporation in the growing DNA chain (8).
This model takes into account the importance of the
chelation of two divalent magnesium ions required in
the polymerization mechanism and bringing the free
30 OH group of the primer for in-line attack of the alpha
phosphate group of dNTP. In line with these observations,
Garforth et al. (9) suggest that enzyme processing could
occur when only two potential chelating moieties are
present.
In the case of phosphoramidate substrates, a necessity
of the leaving group to carry two potential chelating
moieties was conﬁrmed recently as well (10). To broaden
the chemical space and obtain further insight in the struc-
ture–activity relationship, we altered the substitution
pattern of the nitrogen atom of the phosphoramidate
moiety, while (i) taking care of potential chelating
properties and (ii) staying focused on potential metabolic
accessibility of the new leaving group. Enhanced coordi-
nation of the magnesium ion by the leaving group moiety
of the modiﬁed nucleotide might inﬂuence incorporation
kinetics and eﬃciency of the chain elongation reaction. In
addition, iminodiacetic acid (Figure 1c) can be considered
as potentially metabolically accessible and potentially
prone to catabolism into non-toxic cellular constituents
(i.e. glycine and a two-carbon atom fragment). As a
consequence, this degradation reaction may have an
eﬀect on the equilibrium of the nucleotide incorporation
reaction.
The iminodiacetate dAMP phosphoramidate (IDA-
dAMP) (Figure 1c) possesses no chiral centre (ensuring
less stereochemical constraint than for the chiral
L-aspartic acid) and has chelating properties similar to
EDTA. It has been shown recently that protonation of
the pyrophosphate leaving group is important and
facilitated by a neighbouring general acidic residue
in the active site, at least for a polymerase (11). The
presence of a nitrogen atom in iminodiacetate could be
beneﬁcial in this case.
Figure 1. Chemical structure of (a) deoxyadenosine triphosphate
(b) L-Asp-dAMP and (c) IDA-dAMP. The bond to be cleaved during
enzymatic polymerisation is coloured in grey.
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Analyses
Nuclear magnetic resonance (NMR) spectral analyses
were carried out on a Brucker Avance
TM II 300MHz or
500MHz with PAXTI probe. The Bruker Topspin
TM 2.1
software was used to process spectra. Chemical shifts are
expressed in parts per million (ppm) by frequency.
1H and
13C NMR chemical shifts are referenced to an internal
TMS signal (=0.00ppm),
31P NMR chemical shifts
are referenced to an external 85% H3PO4 standard
(=0.00ppm). Standard mass spectra were measured
with a Finnigan LCQ DuO (Thermo Fischer Scientiﬁc)
using the ionization by electron impact technique (ESI);
data were acquired with the LAC/E
32 system (Waters).
Exact mass spectra were obtained with a Q-Tof 2TM
(Micromass Ltd) coupled to a CapLC
TM system
(Waters). Chemicals of analytical or synthetic grade
were obtained from commercial sources and were used
as received [deoxyadenosine monophosphate: Sigma–
Aldrich; dicyclohexylcarbodiimide (DCC), dimethyl
iminodiacetic acid hydrochloride: Fluka; tert-butanol
and triethylamine: Acros]. Technical solvents were
obtained from Brenntag (Deerlijk, Belgium). Acetonitrile
HPLC Grade was purchased from Fischer Scientiﬁc.
Flash silica chromatography was performed on Davisil
silica gel 60, 0.040–0.063mm (Grace Davison). Thin-layer
chromatography was performed on Alugram silica gel
UV254 mesh 60, 0.20mm (Macherey-Nagel).
Synthesis of 20-deoxyadenosine-50-(dimethyl
iminodiacetate) phosphoramidate (intermediate
for IDA-dAMP)
In a two neck ﬂask, 20-deoxyadenosine-50-monophos-
phoric acid hydrate (100mg, 0.286mmol) and dimethyl
iminodiacetate hydrochloride (283mg, 1.430mmol,
5equiv.) were suspended in a mixture of 1,4-dioxane
(9ml) and N,N-dimethylformamide (DMF, 1ml). A few
drops of triethylamine were added to the solution to facil-
itate dissolution. Then, a solution of DCC (414mg,
2.004mmol, 7equiv.) in 1,4-dioxane (1ml) was added
and the reaction mixture was heated for 3h, while
stirring under nitrogen atmosphere. The progress of the
reaction was monitored by TLC (CHCl3:CH3OH:H2O
5:3:0.5). Upon completion, the reaction mixture was
cooled down and the solvent was removed by rotary evap-
oration. The residue was resuspended in water (15ml),
extracted with diethyl ether (3 10ml), and the aqueous
phase was lyophilised. The resulting solid was subjected to
column chromatography on silica gel using the following
solvent gradient: CHCl3:CH3OH:H2O (5:1:0; 5:2:0.25;
5:3:0.25; 5:3:0.5). The product was obtained as a white
solid (58mg, 43%).
1H NMR (500MHz, D2O): d 8.46 (s, 1H, H8), 8.24 (s, 1H,
H2), 6.50 (apparent t, 1H, JH10–H20 =6.5Hz, H10), 4.72
(m, 1H, H30), 4.22 (m, 1H, H40), 4.00 (m, 2H, H50), 3.78
(dd, 2H, J=9.5Hz, CH2COOCH3), 3.69 (dd, 2H,
J=11Hz, CH2COOCH3), 3.56 (s, 6H, CH3), 2.89 (m,
1H, H20a), 2.61 (m, 1H, H20b) ppm.
13C NMR (125MHz, D2O): d 174.27, 156.07, 153.21,
149.36, 140.38, 119.14, 86.63, 84.12, 72.13, 64.67, 52.62,
49.28, 39.25ppm.
31P NMR (121MHz, D2O): d 6.67ppm.
HRMS: calculated for C16H22N6O9P 473.1186, found:
473.1180.
Synthesis of 20-deoxyadenosine-50-iminodiacetate
phosphoramidate
A solution of 20-deoxyadenosine-50-dimethyl iminodia-
cetate phosphoramidate (50mg, 0.105mmol) in 0.4M
sodium hydroxide solution in MeOH:H2O (4:1) (2ml),
was stirred at room temperature under nitrogen for 2h.
The progress of the reaction was monitored by TLC
(iPrOH/NH3/H2O 7:1:2). Upon completion, the reaction
mixture was neutralized by addition of 1M triethylam-
monium bicarbonate. The solvent was removed under
reduced pressure. The residue was puriﬁed by column
chromatography and eluted with the following solvent
gradient: CHCl3:CH3OH:H2O 5:1:0, 5:2:0.25, 5:3:0.5
and 5:4:1. The product was isolated and concentrated,
aﬀording a white solid (31mg, 65% yield).
1H NMR (500MHz, D2O): d 8.46 (s, 1H, H8), 8.25 (s, 1H,
H2), 6.50 (apparent t, 1H,
3JH10–H20 =6.48Hz, H10), 4.70
(m, 1H, H3’), 4.26 (m, 1H, H40), 4.02 (m, 2H, H50), 3.64
(m, 4H, CH2COOH), 2.83 (m, 1H, H20a), 2.59 (m, 1H,
H20b) ppm.
13C NMR (125MHz, D2O): d 171.96, 156.26, 153.35,
149.49, 140.68, 119.41, 86.62, 84.42, 71.87, 64.67, 49.67,
39.62ppm.
31P NMR (121MHz, D2O): d 8.34ppm.
HRMS (ESI): calculated for C14H19N6O9P 446.0951,
found: 445.0864 (negative mode).
Metabolic availability
Trisodium trimetaphosphate (153mg, 0.5mmol) and
iminodiacetic acid disodium salt (979mg, 5mmol,
10equiv.) were dissolved in double-distilled water (6ml)
and the resulting clear mixture was let at r.t. for 1day
and monitored by
31P NMR (121Hz, 90% H2O+10%
D2O). Simultaneously with disappearance of the starting
material (–20.79ppm, s), formation of three news peaks
[–0.39ppm (d, JP–P=20.06Hz), –4.97ppm (d, JP–P=
17.58Hz), –19.65ppm (t, JP–P=18.99Hz)], assigned to
triphosphoro iminodiacetic acid (TPI), was observed
(80% yield, from
31P peak integration). The mixture was
lyophilized; solvent (DMF, DMSO, hexamethylphos-
phoramide or mixture thereof with water) (1ml),
deoxyadenosine (16mg, 0.0625mmol) and magnesium
chloride (127mg, 0.625mmol) were added. The resulting
mixture was stirred at r.t. for 1h and monitored by
31P
NMR. Disappearance of TPI signals was simultaneous
with appearance of two singulets (0.38ppm and
–9.24ppm), attributed to iminodiacetic monophosphate
and to inorganic pyrophosphate, respectively.
Oligodeoxyribonucleotides preparation
Oligodeoxyribonucleotides P1, T1, T2 and T3
were purchased from Sigma Genosys or Eurogentec.
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Cary-300-Bio UV Spectrophotometer.
The lyophilized oligonucleotides were dissolved in
diethylpyrocarbonate (DEPC)-treated water and stored
at –20 C. The primer oligonucleotides were 50-
33P-
labeled with 50-[g
33P]-ATP (Perkin Elmer) using T4
polynucleotide kinase (New England Biolabs), according
to standard procedures. The labelled oligonucleotide was
further puriﬁed using IllustraTM MicrospinTM G-25
columns (GE Healthcare).
DNA polymerase reactions using IDA-dAMP as substrate
End-labelled primer was annealed to its template by
combining primer and template in a molar ratio of 1:2
and heating the mixture to 70 C for 10min, followed by
slow cooling to r.t. over a period of 1.5h. For the incor-
poration of IDA-dAMP a series of 20-ml-batch reactions
was performed with the enzyme HIV-1 RT (Ambion,
10U/ml stock solution, speciﬁc activity 8.095U/mg). The
ﬁnal mixture contained 125nM primer template complex,
RT buﬀer [250mM Tris–HCl, 250mM KCl, 50mM
MgCl2, 2.5mM spermidine, 50mM dithiothreitol (DTT);
pH 8.3], 0.025U/ml HIV-1 RT, and diﬀerent concentra-
tions of IDA-dAMP building blocks (1mM, 500mM,
200mM and 100mM). In the control reaction with the
natural nucleotide, a 10-mM dATP concentration was
used. The mixture was incubated at 37 C and aliquots
were quenched after 5, 10, 20, 30 and 60min. For elonga-
tion experiments, the same mixture with appropriate
primer:template hybrid (Table 1) was incubated at 37 C
and aliquots were quenched after 15, 30, 60, 90, 120min.
In the reaction with the natural nucleotide, a 50-mM dATP
concentration was used.
Steady-state kinetics of single-nucleotide incorporation
The steady-state kinetics of single-nucleotide incorpora-
tion of the iminodiacetate phosphoramidate and of the
natural nucleoside triphosphate (dATP) was determined
by gel-based polymerase assay. In all the experiments,
the template T1 and the primer P1 were used. The
primer and template in a 1:2 molar ratio were hybridized
in a buﬀer containing 20mM Tris–HCl, 10mM KCl,
2mM MgSO4, 0.1% Triton X-100, pH 8.3 and used in
an amount to provide 125nM concentration of the
primer in each 20-ml reaction. A range of building block
concentrations between 10mM and 1mM for the
phosphoramidate and between 0.1 and 10mM for the
natural building block was used. The ﬁnal concentrations
of primer–template complex and HIV-1 RT were 125nM,
and 0.0063U/ml, respectively. Reaction mixtures were
incubated at 37 C and aliquoted at six diﬀerent time inter-
vals. The reactions were quenched by addition of a buﬀer
containing 80% formamide, 2mM EDTA and 1X TBE
buﬀer. The analysis of polymerase reaction was performed
by polyacrylamide gel electrophoresis (see detailed
protocol below). The incorporation rates (V) were
calculated based on the percentage of the extended
oligonucleotide in the mixture (P+1 band). The kinetic
parameters (VMax and KM were determined by plotting
V (nM/min
–1) versus substrate concentration (mM) and
ﬁtting the data to a non-linear Michaelis–Menten regres-
sion using GraphPad Prism Software version 5.0.
Electrophoresis
All polymerase reaction aliquots (2.5ml) were quenched
by the addition of 10ml of loading buﬀer [90% formamide,
0.05% bromophenol blue, 0.05% xylene cyanol and
50mM ethylenediaminetetraacetic acid (EDTA)].
Samples were heated at 85 C for 3min prior to analysis
by electrophoresis for 2.5h at 2000V on a 30cm 
40cm 0.4mm 20% (19:1 mono:bis) denaturing gel
in the presence of a 100mM Tris–borate, 2.5mM EDTA
buﬀer; pH 8.3. Products were visualized by phosphori-
maging. The amount of radioactivity in the bands corre-
sponding to the products of enzymatic reactions was
determined by using the imaging device Cyclone and
the Optiquant image analysis software (Perkin Elmer).
Molecular modelling
Modelling of the iminodiacetate-dAMP in the RT active
site was prepared and performed as previously described
(12–14). Solvated molecular dynamics was used to verify
the stability. The complex was solvated and simulated for
1ns. The presence of the base pair hydrogen bonds
between primer and template strand was taken as a valid
indicator for the stability of the structures: nearly all
H-bonds were still present in the ﬁnal dynamic structures.
An average structure of the last 50ps was generated and
analysed.
RESULTS AND DISCUSSION
Synthesis of IDA-dAMP
The synthesis of the methyl esters of the IDA-dAMP 1
was accomplished according to the method described by
Wagner and colleagues (15) starting from the nucleoside
monophosphate. Deprotection of the methyl ester was
carried out with sodium hydroxide in methanol–water
solution. Scheme 1 shows the synthetic route, which is
an easy-to-perform two-step reaction.
Single-Nucleotide Incorporation
HIV-1 reverse transcriptase serves as a catalyst in the
HIV-1 viral replication process and uses deoxynucleotides
as substrates. This polymerase is error-prone and thus has
Table 1. Overview of the primer-template complexes used in the
DNA polymerase reactions
Single-nucleotide incorporation and kinetic experiments
P1 50-CAGGAAACAGCTATGAC-30
T1 30-GTCCTTTGTCGATACTGTCCC-50
Elongation experiments
P1 50-CAGGAAACAGCTATGAC-30
T2 30-GTCCTTTGTCGATACTGTTTTTTT-50
T3 30-GTCCTTTGTCGATACTGTTTTTTTGGAC-50
Bold letters indicate the template overhang in the hybridized primer–
template duplex.
2544 Nucleic Acids Research, 2010,Vol.38, No. 8a high mutation rate (16,17). Previous experiments carried
out with the L-aspartic acid phosphoramidate of dAMP
demonstrated that this amino acid was an acceptable
leaving group for the polymerase in the nucleotidyl con-
densation process (5,6). In the present study, we evaluated
the capacity of HIV-1 RT to incorporate IDA-dAMP as a
substrate in the primer- template complex P1:T1. The
initial experiments were carried out using a template
with an overhang of one thymidine nucleotide followed
by three non-pyrimidine bases (Table 1). Incorporation
eﬃciency was analysed by the polyacrylamide-gel-based
single-nucleotide incorporation assay (18,19).
The phosphoramidate analogue IDA-dAMP was
correctly processed by HIV-1 RT converting a primer to
an (P+1) strand up to 86% in 60min, at 500mM
deoxynucleotide concentration (Figure 2). So as for
L-Asp-dAMP, eﬃcient substrate incorporation was also
detected with a 5-fold lower substrate concentration
(40% P+1 product at 100mM).
Elongation experiments
Previous studies carried out with L-Asp-dAMP and HIV-1
RT showed its ability to serve as a substrate for
template-dependent incorporation of more than one
phosphoramidate nucleotide. Primer elongation of up to
6nt was observed but only to a limited extent, and with
prevalence of the (P+2) and (P+3) products. Such a
stalling represents a signiﬁcant hindrance for future use
of phosphoramidate nucleotides for enzymatic DNA syn-
thesis in vivo. For the evaluation of the strand elongation
capacity of IDA-dAMP using the same enzyme, the
primer–template duplexes P1:T2 and P1:T3 were used
(Table 1).
A range of concentrations of the building block
was incubated at the appropriate temperature with
the primer–template complex and 0.025U/ml of enzyme.
Samples were taken between 30 and 120min and analysed
by 20% polyacrylamide gel electrophoresis. In the P1:T2
experiment, the template has an overhang of seven
thymidine nucleotides. With IDA-dAMP, we observed a
prevalence of the (P+6) product, disclosing an excellent
elongation capacity (Figure 3). The initial stalling at the
(P+2) and (P+3) products disappears over time and is
not so pronounced as with L-Asp as substrate (Table 2).
However, we did not observe a complete chain extension
to (P+7) products when using the P1:T2 system.
The major product of L-Asp-dAMP incorporation is the
(P+2) resulting oligonucleotide, whereas the (P+6)
Figure 3. Elongation of P1:T2 with IDA-dAMP by HIV-1 reverse transcriptase. Aliquots were taken at 15, 30, 60, 90 and 120min. Blank: no
triphosphate analogue was added in the reaction.
Figure 2. Incorporation of IDA-dAMP and L-Asp-dAMP into P1:T1 by HIV-1 reverse transcriptase. Aliquots were taken at 5, 10, 20, 30 and
60min.
Scheme 1. Obtention of IDA-dAMP 1.
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tiﬁable. In contrast, with IDA-dAMP, the major product
is the (P+6) oligonucleotide (Table 2).
In the subsequent P1:T3 experiment using a P1:T3
duplex, where the seven thymidine bases overhang of the
template is ﬂanked by four non-thymidine units, the
primer extension resulted in formation of a (P+7)
product (Figure 4).
The observed full-length elongation obtained when
using the purine-elongated template T3, could be due to
the increased aﬃnity of the longer template overhang for
the enzyme and the formation of a more stable tertiary
complex. As was suggested by Kohlstaedt in 1992, it has
been shown that the template strand binds to the ﬁngers
subdomain of the polymerase active site (20–22). Besides,
the binding aﬃnity of RT with DNA duplexes is increased
when template overhang is extended to six additional
bases (23). From models based on crystal structures of
the complex (23,24), the b3–b4 loop, situated in this
domain, contacts the template 3nt upstream from the
primer terminus (near or at Leu
74). Kew et al. (25)
postulated that a stronger complex between the ﬁngers
subdomain of a HIV-RT and the template overhang
may be responsible for higher processivity by the enzyme.
Although it seems that binding and incorporation of a
natural triphosphate substrate dATP is not dependent on
the length of the template overhang (24) (Figure 3), it
appears to be the case with the triphosphate mimic
IDA-dAMP. The presence of a four base 50-overhang at
the template’s 50-end could favour a more stable dsDNA–
protein complex. The template length also seems to inﬂu-
ence the ability of HIV-1 RT to recognise and incorporate
an incoming dNTP carrying a modiﬁed leaving group.
The superior substrate properties of IDA-dAMP as
compared to L-Asp-dAMP might also be arising from
the increased chelating ability of the N-diacetate group
of IDA-dAMP when compared with the aspartate group
of L-Asp-dAMP, from structural diﬀerences of the transi-
tion state or from modiﬁed conformational changes of the
enzyme. In the case of T7 RNA polymerase, Yin and
Steitz proposed a model where cross-linking between the
DNA helix and the enzyme depends on the presence of
pyrophosphate. They demonstrated that the nature of the
electrostatic interactions of this complex undergo changes
between the pre- and post-translocation state of nucleotide
incorporation (26). In a previous model postulated by
Steitz, one magnesium ion is coordinated by the 30 end
of the primer and the a-phosphate, while the second mag-
nesium ion is thought to facilitate the leaving group
properties of the pyrophosphate moiety by chelating
with the b- and g-phosphates of the nucleotide (8).
Both iminodiacetic acid and aspartic acid have good
chelating properties. These dicarboxylic acids display dis-
sociation constants (KD,25 C) for the divalent magnesium
ion of 2.98 and 2.43, respectively, while the dissociation
constant of pyrophosphate is 5.4 (27). The observed elon-
gation demonstrates that iminodiacetic acid has func-
tioned as a leaving group. If the reaction mechanism of
the chemical step mimics that of the natural substrate, one
magnesium ion should leave the catalytic site together
with the leaving group. If this happens, given that the
amino group participates in a phosphoramidate bond,
the contribution of the lone pair on the nitrogen atom
to the chelating properties of the leaving group is
reduced before phosphoryl transfer, but not when the
P–N bond has been cleaved (coordination of
iminodiacetate).
Kinetic experiments
Further investigation of IDA-dAMP was focused on
kinetics of incorporation. Kinetic parameters for the
incorporation of both the natural and the modiﬁed
substrate by HIV-1 RT were determined on the basis
of the single completed hit model (19,28); in the study
Figure 4. Elongation of P1:T3 with IDA-dAMP by HIV-1 reverse transcriptase. Aliquots were taken at 15, 30, 60, 90 and 120min. Blank: no
triphosphate analogue was added in the reaction.
Table 2. L-Asp-dAMP versus IDA-dAMP in the elongation of P1
directed by template T2: % of P+n product after a 120-min reaction
Product % substrate
a
L-Asp-dAMP (6)
% substrate
a
IA-dAMP
P+6 Traces 40 (major)
P+5 Traces 19
P+4 Traces 3
P+3 34 14
P+2 64 (major) 12
aPercentage of the total amount of radio-emitting oligonucleotides in
the mixture.
2546 Nucleic Acids Research, 2010,Vol.38, No. 8P1 and T1 (Table 1) were used as the primer and template
DNA strands, respectively. The steady-state kinetic values
KM and VMax corresponding to the substrate eﬃciency of
the nucleotide triphosphate analogues are reported in
Table 3.
Along with showing a similar single incorporation after
60min and far better elongation results, IDA-dAMP also
demonstrates better incorporation kinetics than
L-Asp-dAMP for HIV-1 RT (5). The measured VMax/KM
ratio towards HIV-1 RT is 1 order of magnitude
lower than that of dATP. Similarly to the L-Asp
phosphoramidate analogue, the KM of IDA-dAMP is
much higher than for the natural substrate, whereas the
VMax is 1.3-fold lower. The increased capacity for chain
elongation is paralleled by a similar increase in incorpo-
ration eﬃciency. It is clear that enzyme evolution should
focus on the selection of a polymerase enhancing KM
(rather than VMax) which is easier to achieve than the
inverse.
Model of IDA-dAMP (1) bound to HIV-1 reverse
transcriptase
With the IDA-dAMP molecule bound to HIV-1 RT,
stable molecular dynamics (MD) trajectories were
obtained. In the calculated ground-state complex (Figure
5b), the spatial arrangement of two Mg
2+ ions is compa-
rable to their situation in the original TTP complex
(Figure 5a) (21). Although in the ground state the
carboxylate groups of IDA-dAMP (mimicking the b and
g phosphate groups) are not yet involved in an ionic bond
with the Mg
2+ ions, they are stabilized by ionic interac-
tions with Lys65A, Arg72A and Gln151A. The diﬀerence
in binding aﬃnity between PPi and IDA could also con-
tributes to a diﬀerence in kinetics or to the lower
processivity of the enzyme when challenged with
IDA-dAMP in place of dATP (29). In the crystal structure
obtained with a dNTP, Gln151 only contacts the dTTP,
without forming an actual ionic bond (21).
The divalent magnesium ions are located in a very
strong network of ionic bonds that involves the non-
bridging oxygen of the phosphoramidate group and the
three aspartate residues Asp185A, Asp110A and
Asp186A, which are highly conserved in the polymerase
family (22,23). The ionic bond interaction observed
Figure 5. (a) The thymidine triphosphate (TTP) in the RT dNTP pocket [X-ray structure from Huang 1998 (18)]. The primer strand is shown as a
green ribbon; the template strand is in blue. The stabilizing interactions of the TTP within the complex are shown: hydrogen bond distances between
the bases are indicated in angstroms. The ligation of the 2 Mg
2+ ions to the complex is also visualized by dashes and distances in angstroms.
(b) Average structure of IDA-dAMP in the RT dNTP binding pocket. This ﬁgure was generated using Bobscript, Molscript and Raster3d (37–39).
Table 3. Determination of the kinetic parameters of the incorporation
of dAMP with the natural pyrophosphate leaving group (dATP) and
the iminodiacetate leaving group (IDA-dAMP) into P1T1 by HIV-1
RT DNA polymerase at 0.025U/ml
KM (mM) Vmax (nMmin
 1) Vmax/KM (min
 1)
dATP 29±5 65.7±4.3 2.26 10
 3
IDA-dAMP 312.5±70.5 49.0±4.5 0.16 10
 3
Nucleic Acids Research,2010, Vol.38, No. 8 2547between the divalent cation and residue Asp186A in the
ground state is speciﬁcally noted in the complex of HIV-1
RT with IDA-dAMP and Asp-dAMP (6,30).
Metabolic accessibility
In order to investigate the metabolic accessibility and
recycling potential of a novel triphosphate mimic, we
synthesized triphospho-iminodiacetate (TPI) and tested
the possibility of displacement of a pyrophosphate
moiety by deoxyadenosine (Scheme 2). The triphosphate
was formed by the reaction of trimetaphosphate with
iminodiacetic acid, by adapting the method described by
Feldmann et al. (31). Pyrophosphate displacement
reaction with deoxyadenosine in the presence of
magnesium ions with release of pyrophosphate was,
however, not successful due to poor nucleophilicity of
the 50-hydroxyl group of deoxyadenosine and solubility
problems. On the other hand, cleavage of cyclic
trimetaphosphate by adenosine in the presence of MgCl2
in neutral conditions was previously observed by
Yamagata (32). The presence of a divalent cation
that would facilitate the pyrophosphate displacement
implies the use of a non-nucleophilic polar solvent.
Therefore further experiments are needed to be done to
circumvent the solubility problems. Another approach to
solve the aforementioned diﬃculty with pyrophosphate
displacement is to develop aptamers/aptazymes to
catalyse the reaction.
CONCLUSION AND PERSPECTIVES
Deoxyadenosine triphosphate analogues in which the
pyrophosphate moiety is replaced by L-aspartic acid
had previously been shown to act as substrates for
DNA polymerisation catalysed by HIV-1 RT. Using
iminodiacetate dAMP as a possible substrate improved
incorporation and elongation results are obtained.
The contribution of the pyrophosphate leaving group
to DNA synthesis, in terms of catalytic eﬃciency and
ﬁdelity of DNA polymerase b, was studied recently (33).
These data suggest a leaving-group-induced change
in the rate-limiting step due to stabilization of
pyrophosphate group release. It is clear that the substitu-
tion of pyrophosphate group by L-Asp and IDA moieties
would be likely to have a major impact on this process.
Furthermore, chemical modiﬁcation of the leaving group
inﬂuences active-site structural diﬀerences between correct
and incorrect base-paired transition state (34).
Elongation results with IDA-dAMP allowed us to con-
ﬁrm the positive inﬂuence of a longer template overhang
for the recognition and incorporation of several successive
units carrying a modiﬁed leaving group. Therefore, our
results validated the importance of interactions between
ﬁnger subdomain residues and the template’s upstream
nucleotides during the HIV-1 RT directed DNA synthesis.
Modelling experiments showed us that in the ground
state, the carboxylate groups are most likely to be
bound to an intricate network of amino acid residues
Lys65, Arg72 and Gln151 located in the enzyme’s active
site via divalent cations. Our study suggests that in the
ground state the magnesium ion could form an ionic
bond with Asp110, Asp185 and Asp186. The last interac-
tion mentioned (Asp186) is observed only in the case of
IDA-dAMP and L-Asp-dAMP. This model could suggest
that in the ground state, the stabilization of IDA-dAMP is
enhanced, involving six amino acid residues instead of
four with the natural substrate and ﬁve with Asp-dAMP
(6). The increase in amino acids interactions observed in
the complex formation with IDA-dAMP is not reﬂected in
a change in KM. The electrostatic involvement of residues
Gln155A and Asp186A has not been observed in previous
studies (6). The diﬀerence in binding aﬃnity between
pyrophosphate and iminodiacetic acid is likely to contrib-
ute to a diﬀerence in kinetics (29). In addition, the diﬀer-
ence in intrinsic energy of the released leaving group could
be a possible ‘brake’ for further conformational changes
of the enzyme (26,29).
The nucleoside phosphoramidates developed in this
study lend themselves to metabolic implementation, as
described in Scheme 2. With the help of the divalent mag-
nesium cation, a further nucleophilic attack of the
a-phosphate by the 50 hydroxyl group of adenosine
should form the phosphoramidate 1, with the energetically
favoured release of a pyrophosphate. Biosynthesis would
start from the two common metabolites glycine and
glyoxylate, that is its corresponding 2-oxo-acid. A
speciﬁc transaminase (serine-glyoxylate aminotransferase)
performs interconversion of glycine and glyoxylate in
certain methylotrophic bacteria (35). Reductive condensa-
tion to glycine with glyoxylate resulting in iminodiacetate
is reminiscent to octopin biosynthesis, and enzymes in
charge of the production of these nutrient shuttles could
be harnessed for our purpose (36,37). Furthermore,
ammonia reacts in neutral aqueous media with
cyclotriphosphate to yield triphosphoramidates and equi-
librium constant of this reaction is about 1.52min
–1 (31).
Scheme 2. Hypothesized metabolic pathway towards iminodiacetic acid deoxyadenosine phosphoramidate.
2548 Nucleic Acids Research, 2010,Vol.38, No. 8We propose that this reaction could be readily observed in
the case of the secondary amine IDA, spontaneously pro-
viding TPI in good yield (80% yield after 24h at room
temperature). Putative enzymes capable of accelerating
this spontaneous reaction could possibly be found in the
class of hydrolases that act on acid anhydrides, such as
trimetaphosphatase (EC 3.6.1.2) (38). Our study though
showed further condensation of TPI with the 50 hydroxyl
of the nucleoside deoxyadenosine did not proceed
spontaneously under the various conditions tested.
Nevertheless, since this reaction features the nucleophilic
attack of a phosphoanhydride by a primary alcohol as
performed by many kinases, the systematic assay of such
enzymes can unveil a biocatalyst marginally endowed with
the desired activity.
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